Qube Research & Technologies (QRT)
DAWN

Qube Research & Technologies (QRT)’s Day One Biopharmaceuticals DAWN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,954,552
Closed -$41.9M – 3579
2026
Q1 		$41.9M Buy
1,954,552
+467,990
+31% +$6.59M 0.05% 500
2025
Q4 		$13.9M Buy
1,486,562
+318,893
+27% +$2.66M 0.01% 1128
2025
Q3 		$8.23M Buy
1,167,669
+223,467
+24% +$1.54M 0.01% 1439
2025
Q2 		$6.14M Buy
944,202
+663,418
+236% +$4.56M 0.01% 1581
2025
Q1 		$2.23M Buy
280,784
+96,128
+52% +$1.04M ﹤0.01% 1913
2024
Q4 		$2.34M Buy
184,656
+94,468
+105% +$1.31M ﹤0.01% 1817
2024
Q3 		$1.26M Buy
90,188
+44,536
+98% +$635K ﹤0.01% 1944
2024
Q2 		$629K Buy
+45,652
New +$668K ﹤0.01% 2071
2023
Q2 		– Sell
-104,327
Closed -$1.39M – 2504
2023
Q1 		$1.39M Buy
104,327
+91,057
+686% +$1.78M 0.01% 1161
2022
Q4 		$286K Buy
+13,270
New +$272K ﹤0.01% 1669

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DAWN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 1,954,552 shares — an estimated $41.9M sold.

Qube Research & Technologies (QRT) first reported a position in DAWN in Q4 2022 and held it in 10 quarters. The position peaked at $41.9M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,954,552 Day One Biopharmaceuticals shares in Q2 2026, an estimated $41.9M.
  • Qube Research & Technologies (QRT) first reported a position in Day One Biopharmaceuticals in Q4 2022 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Day One Biopharmaceuticals position peaked at $41.9M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.